Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allopurinol as a Possible New Therapy for Acute Coronary Syndromes:The Next Steps

NCT01457820 is registered in ClinicalTrials.gov with Stephen McSwiggan as lead sponsor.

NCT NCT01457820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01457820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allopurinol as a Possible New Therapy for Acute Coronary Syndromes:The Next Steps
Lead sponsor
Stephen McSwiggan
Phase
Phase 4
Overall status
Terminated
Start date
April 30, 2012
Completion date
March 31, 2015
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic stable angina